Clinical-stage biotechnology company PYC Therapeutics (ASX:PYC) has announced a leadership transition, with Chair Alan Tribe appointed as Managing Director following the resignation of Dr Rohan Hockings, who has served as Chief Executive Officer and Executive Director since 2018.
Interview
New Stories
-
PYC Therapeutics announces leadership transition as chair Asteps in as managing director
September 17, 2025 - - AusBiotech -
BlinkLab expands US clinical trial network with University of Missouri’s Thompson Center
September 17, 2025 - - AusBiotech -
EMVision secures $12 million to drive breakthrough stroke imaging programs
September 17, 2025 - - AusBiotech -
Island Pharmaceuticals reports breakthrough survival data for galidesivir in Marburg and Ebola studies
September 17, 2025 - - AusBiotech -
CSL partners with VarmX on first-in-class coagulation treatment
September 16, 2025 - - Latest News -
Alterity Therapeutics delivers promising Phase 2 data in Multiple System Atrophy
September 15, 2025 - - Latest News -
Actinogen secures FDA agreement to advance Xanamem for Alzheimer’s disease
September 15, 2025 - - Latest News